Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001682852-23-000021
Filing Date
2023-05-04
Accepted
2023-05-04 16:03:31
Documents
93
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mrna-20230331.htm   iXBRL 10-Q 1594633
2 EX-31.1 exhibit31133123.htm EX-31.1 9244
3 EX-31.2 exhibit3123312023.htm EX-31.2 9191
4 EX-32.1 exhibit3213312023.htm EX-32.1 8321
10 mrna-20230331_g1.jpg GRAPHIC 63925
11 mrna-20230331_g2.jpg GRAPHIC 601303
  Complete submission text file 0001682852-23-000021.txt   10109151

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrna-20230331.xsd EX-101.SCH 53665
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrna-20230331_cal.xml EX-101.CAL 111801
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrna-20230331_def.xml EX-101.DEF 229251
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrna-20230331_lab.xml EX-101.LAB 662764
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrna-20230331_pre.xml EX-101.PRE 445561
87 EXTRACTED XBRL INSTANCE DOCUMENT mrna-20230331_htm.xml XML 1728656
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

EIN.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38753 | Film No.: 23888537
SIC: 2836 Biological Products, (No Diagnostic Substances)